skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: p53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [2];  [3];  [1]; ; ; ;  [1];  [4];  [5];  [4];  [6];  [7];  [1]
  1. Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan (China)
  2. Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan (China)
  3. Department of Medical Research and Education, Cheng Hsin General Hospital, Taipei, Taiwan (China)
  4. Institute of Biotechnology, National Cheng-Kung University, Tainan, Taiwan (China)
  5. Department of Surgical Oncology, Cheng Hsin General Hospital, Taipei, Taiwan (China)
  6. Department of Dermatology, Taichung Veterans General Hospital, Taichung, Taiwan (China)
  7. Department of Bioscience Technology, Chang Jung Christian University, Tainan, Taiwan (China)

Compound C, a well-known inhibitor of the intracellular energy sensor AMP-activated protein kinase (AMPK), has been reported to cause apoptotic cell death in myeloma, breast cancer cells and glioma cells. In this study, we have demonstrated that compound C not only induced autophagy in all tested skin cancer cell lines but also caused more apoptosis in p53 wildtype skin cancer cells than in p53-mutant skin cancer cells. Compound C can induce upregulation, phosphorylation and nuclear translocalization of the p53 protein and upregulate expression of p53 target genes in wildtype p53-expressing skin basal cell carcinoma (BCC) cells. The changes of p53 status were dependent on DNA damage which was caused by compound C induced reactive oxygen species (ROS) generation and associated with activated ataxia-telangiectasia mutated (ATM) protein. Using the wildtype p53-expressing BCC cells versus stable p53-knockdown BCC sublines, we present evidence that p53-knockdown cancer cells were much less sensitive to compound C treatment with significant G2/M cell cycle arrest and attenuated the compound C-induced apoptosis but not autophagy. The compound C induced G2/M arrest in p53-knockdown BCC cells was associated with the sustained inactive Tyr15 phosphor-Cdc2 expression. Overall, our results established that compound C-induced apoptosis in skin cancer cells was dependent on the cell's p53 status. - Highlights: ► Compound C caused more apoptosis in p53 wildtype than p53-mutant skin cancer cells. ► Compound C can upregulate p53 expression and induce p53 activation. ► Compound C induced p53 effects were dependent on ROS induced DNA damage pathway. ► p53-knockdown attenuated compound C-induced apoptosis but not autophagy. ► Compound C-induced apoptosis in skin cancer cells was dependent on p53 status.

OSTI ID:
22285245
Journal Information:
Toxicology and Applied Pharmacology, Vol. 267, Issue 1; Other Information: Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English